WASHINGTON - The US Food and Drug Administration on Friday authorized an extremely expected brand-new drug designed to slow cognitive decrease in patients in the early phases of Alzheimers disease.
Music
Trailers
DailyVideos
India
Pakistan
Afghanistan
Bangladesh
Srilanka
Nepal
Thailand
StockMarket
Business
Technology
Startup
Trending Videos
Coupons
Football
Search
Download App in Playstore
Download App
Best Collections